Reply to Schramm, L. Comment on "Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364"
- PMID: 35328170
- PMCID: PMC8947584
- DOI: 10.3390/diagnostics12030617
Reply to Schramm, L. Comment on "Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364"
Abstract
We thank Professor Laura Schramm for her comment on the history and clarification of BDP1 nomenclature, her contribution to gene cloning [...].
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364.Diagnostics (Basel). 2022 Feb 28;12(3):608. doi: 10.3390/diagnostics12030608. Diagnostics (Basel). 2022. PMID: 35328161 Free PMC article.
-
BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study.Diagnostics (Basel). 2021 Dec 15;11(12):2364. doi: 10.3390/diagnostics11122364. Diagnostics (Basel). 2021. PMID: 34943600 Free PMC article.
-
BDP1 Alterations Correlate with Clinical Outcomes in Breast Cancer.Cancers (Basel). 2022 Mar 25;14(7):1658. doi: 10.3390/cancers14071658. Cancers (Basel). 2022. PMID: 35406430 Free PMC article.
-
Reply to Ferrés-Padró et al. Comment on "Lionte et al. Association of Multiple Glycemic Parameters at Hospital Admission with Mortality and Short-Term Outcomes in Acutely Poisoned Patients. Diagnostics 2021, 11, 361".Diagnostics (Basel). 2021 Jun 4;11(6):1032. doi: 10.3390/diagnostics11061032. Diagnostics (Basel). 2021. PMID: 34199693 Free PMC article.
-
Reply to Vrijdag et al. Comment on "Mankowska et al. Critical Flicker Fusion Frequency: A Narrative Review. Medicina 2021, 57, 1096".Medicina (Kaunas). 2022 Jun 6;58(6):765. doi: 10.3390/medicina58060765. Medicina (Kaunas). 2022. PMID: 35744028 Free PMC article. Review.
References
-
- Schramm L. Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364. Diagnostics. 2022;12:608. doi: 10.3390/diagnostics12030608. - DOI - PMC - PubMed
-
- Li X., Sun L., Stucky A., Tu L., Cai J., Chen X., Wu Z., Jiang X., Li S.C. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics. 2021;11:2364. doi: 10.3390/diagnostics11122364. - DOI - PMC - PubMed